[O-31] 一般演題口演セッション31
治療創薬・再生医療１ E

[O-31-8] Efficacy and safety of ofatumumab versus teriflunomide in relapsing multiple sclerosis

^○Krishnan Ramanathan¹, Stephen L. Hauser², Amit Bar-or³, Jeffrey Cohen⁴, Giancarlo Comi⁵, Jorge Correale⁶, Patricia K. Coyle⁷, Anne H. Cross⁸, Jérôme De. Seze⁹, Xavier Montalban Et Al.¹⁰ (1.Novartis Pharma AG, 2.Department of Neurology, UCSF Weill Institute for Neurosciences, University of California, 3.Center for Neuroinflammation and Experimental Therapeutics and Department of Neurology, Perelman School of Medicine, University of Pennsylvania, 4.Neurological Institute, Cleveland Clinic, 5.University Vita-Salute San Raffaele, 6.Institute for Neurological Research Dr. Raul Carrea, 7.Stony Brook University, 8.Washington University School of Medicine, 9.University Hospital of Strasbourg, 10.St Michael's Hospital, University of Toronto)